At the IUPAC 2014 meeting in San Francisco, Monsanto (acquired by Bayer in 2018) presented ‘Tioxazafen: A new broad-spectrum seed treatment nematicide’ which was discovered with the help of Cresset’s software.
At the IUPAC 2014 meeting in San Francisco, Monsanto (acquired by Bayer in 2018) presented ‘Tioxazafen: A new broad-spectrum seed treatment nematicide’ which was discovered with the help of Cresset’s software.